Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus

Pediatrics

Volumn 115, Issue 5, 2005, Pages 1320-1324

  Alemzadeh, Ramin ^a,b   Berhe, Tseghai ^a   Wyatt, David T ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

BMI; Glargine; Hemoglobin A1c; Hypoglycemia; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LONG ACTING INSULIN;

ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; NUTRITIONAL ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; BLOOD; CHILD; CLINICAL TRIAL; FEASIBILITY STUDY; OBESITY;

BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEASIBILITY STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; MALE; OBESITY;

EID: 25144504444     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1439     Document Type: Article

References (38)

1. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ. 2004;328:750-754
2. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355:873-876
3. Kushion W, Salisbury PJ, Seitz KW, Wilson BE. Issues in the care of infants and toddlers with insulin-dependent diabetes mellitus. Diabetes Educ. 1991;17:107-110
4. Hatton DL, Canam C, Thorne S, Hughes AM. Parents' perceptions of caring for an infant or toddler with diabetes. J Adv Nurs. 1995;22:569-577
5. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care. 2004;27:955-962
6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986
7. Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P. Use of insulin pump therapy at nighttime only for children 7-10 years of age with type 1 diabetes. Diabetes Care. 2000;23:579-581
8. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy in children and adolescents: an option for routine diabetes care. Pediatrics. 2001;107:351-356
9. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr. 2002;141:490-495
10. Rutledge KS, Chase HP, Klingensmith GJ, Walravens PA, Slover RH, Garg SK. Effectiveness of postprandial Humalog in toddlers with diabetes. Pediatrics. 1997;100:968-972
11. Mohn A, Dunger DB, Chiarelli F. The potential role of insulin analogues in the treatment of children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab. 2001;14:349-357
12. Alemzadeh R, Palma-Sisto P, Parton E, Totka J, Kirby M. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus. Acta Diabetol. 2003;40:137-142
13. Burge MR, Schade DS. Insulins. Endocrinol Metab Clin North Am. 1997;26:575-598
14. Rosskamp RH, Park G. Long-acting insulin analogs. Diabetes Care. 1999;22:B109-B113
15. Hathout EH, Fujishige L, Geach J, Ischandar M, Maruo S, Mace JW. Effect of therapy with insulin glargine (Lantus) on glycemic control in toddlers, children, and adolescents with diabetes. Diabetes Technol Ther. 2003;5:801-806
16. American Diabetes Association and the American Dietetic Association. The First Step in Diabetes Meal Planning. Alexandria, VA: American Diabetes Association; 1995
17. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240-1243
18. Chase HP, Dixon B, Pearson J, et al. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr. 2003;143:704-706
19. 1c in children and adolescents with poorly controlled type 1 diabetes. Pediatr Diabetes. 2003;4:64-69
20. Diabetes Control and Complications Trial Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care. 1998;11:567-573
21. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22:1779-1784
22. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care. 2003;26:2871-2875
23. Strauss RS, Pollock HA. Epidemic increase in childhood overweight: 1986-1998. JAMA. 2001;286:2845-2848
24. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342:381-389
25. Chase HP. Glycemic control in prepubertal years. Diabetes Care. 2003;26:1304-1305
26. 1c and body mass index in children and adolescents with IDDM: an observational study from 1976-1995. Exp Clin Endocrinol Diabetes. 2000;108:76-80
27. Alemzadeh R, Goldberg T, Fort P, Becker B, Lifshitz F. Reported dietary intakes of patients with insulin-dependent diabetes mellitus: limitations of dietary recall. Nutrition. 1992;8:87-93
28. Donaghue KC, Fairchild JM, Craig ME, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications? Diabetes Care. 2003;26:1224-1229
29. Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med. 1991;90:450-454
30. Diabetes Control and Complications Trial Research Group. Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care. 1995;18:1415-1427
31. Bott S, Bott U, Berger M, Muhlhauser I. Intensified insulin therapy and the risk of severe hypoglycemia. Diabetologia. 1997;40:926-933
32. Pampanelli S, Fanelli C, Lalli C, et al. Long-term intensive therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycemia, status of counter-regulation and awareness of hypoglycemia. Diabetologia. 1996;39:677-686
33. Allen C, LeCaire T, Palta M, Daniels K, Meredith M, D'Alessio DJ. Risk factors for frequent and severe hypoglycemia in type 1 diabetes. Diabetes Care. 2001;24:1878-1881
34. Clarke WL, Gonder-Frederick L, Cox D. The frequency of severe hypoglycemia in children with insulin-dependent diabetes mellitus. Horm Res. 1996;45:24-52
35. Nordfeldt S, Ludvigsson J. Severe hypoglycemia in children with IDDM: a prospective population study 1992-1994. Diabetes Care. 1997;20:497-503
36. Nordfeldt S, Ludvigsson J. Adverse events in intensively treated children and adolescents with type 1 diabetes. Acta Paediatr. 1999;88:1184-1193
37. Janssen MM, Snoek FJ, de Jongh RT, Casteleijn S, Deville W, Heine RJ. Biological and behavioral determinants of the frequency of mild, biochemical hypoglycemia in patients with type 1 diabetes on multiple insulin injection therapy. Diabetes Metab Res Rev. 2000;16:157-163
38. Alemzadeh R, Loppnow C, Parton E, Kirby M. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther. 2003;5:167-173